PAP
RXRX icon

Persistent Asset Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Persistent Asset Partners’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,999
Closed -$20 – 454
2025
Q4 		$20 Buy
1,999
+393
+24% +$1.95K ﹤0.01% 357
2025
Q3 		$37.7K Hold
1,606
– – 0.03% 190
2025
Q2 		$61.8K Hold
1,606
– – 0.05% 142
2025
Q1 		$79.9K Buy
1,606
+700
+77% +$5.1K 0.07% 120
2024
Q4 		$168K Buy
+906
New +$6.09K 0.14% 92

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return